Mersana Therapeutics Price to Free Cash Flow Ratio 2016-2022 | MRSN
Historical price to free cash flow ratio values for Mersana Therapeutics (MRSN) since 2016.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Mersana Therapeutics Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2022-05-20 |
3.49 |
|
0.00 |
| 2022-03-31 |
3.99 |
$-1.70 |
0.00 |
| 2021-12-31 |
6.22 |
$-1.99 |
0.00 |
| 2021-09-30 |
9.43 |
$-1.75 |
0.00 |
| 2021-06-30 |
13.58 |
$-1.50 |
0.00 |
| 2021-03-31 |
16.18 |
$-1.17 |
0.00 |
| 2020-12-31 |
26.61 |
$-1.22 |
0.00 |
| 2020-09-30 |
18.62 |
$-1.25 |
0.00 |
| 2020-06-30 |
23.40 |
$-1.36 |
0.00 |
| 2020-03-31 |
5.83 |
$-1.22 |
0.00 |
| 2019-12-31 |
5.73 |
$-1.57 |
0.00 |
| 2019-09-30 |
1.58 |
$-1.88 |
0.00 |
| 2019-06-30 |
4.05 |
$-1.99 |
0.00 |
| 2019-03-31 |
5.26 |
$-2.48 |
0.00 |
| 2018-12-31 |
4.08 |
$-2.46 |
0.00 |
| 2018-09-30 |
10.00 |
$-3.95 |
0.00 |
| 2018-06-30 |
17.86 |
$9.88 |
1.81 |
| 2018-03-31 |
15.77 |
$-4.42 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.335B |
$0.000B |
|
Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.
|
